Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Inhibition of the CRBN-DDB1-CUL4-ROC1 E3 Ubiquitin Ligase Mediates the Anti-Proliferative and Immunomodulatory Properties of Lenalidomide

Jan Krönke, Anupama Narla, Slater N. Hurst, Namrata Udeshi, Monica Schenone, Marie McConkey, Peter Grauman, Dirk Heckl, Randall McAuley, Christie Ciarlo, Eamon Comer, Xiaoyu Li, Steven A. Carr, Benjamin L. Ebert

Blood (2012) 120 (21): 919.

https://doi.org/10.1182/blood.V120.21.919.919

Published: 2012

Journal Articles

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome

Madhu S. Kumar, Anupama Narla, Atsushi Nonami, Ann Mullally, Nadya Dimitrova, Brian Ball, J. Randall McAuley, Luke Poveromo, Jeffrey L. Kutok, Naomi Galili, Azra Raza, Eyal Attar, D. Gary Gilliland, Tyler Jacks, Benjamin L. Ebert

Blood (2011) 118 (17): 4666–4673.

https://doi.org/10.1182/blood-2010-12-324715

Published: 2011

Includes: Supplemental data

Journal Articles

Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis

Anupama Narla, Shilpee Dutt, J. Randall McAuley, Fatima Al-Shahrour, Slater Hurst, Marie McConkey, Donna Neuberg, Benjamin L. Ebert

Blood (2011) 118 (8): 2296–2304.

https://doi.org/10.1182/blood-2010-11-318543

Published: 2011

Includes: Supplemental data

Journal Articles

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Rafael Bejar, MD, PhD, Kristen Stevenson, Omar Abdel-Wahab, MD, McConkey Marie, PhD, Katherine Lin, James Randall McAuley, Kevin Cheung, MD, Naomi Galili, Ph.D., Guillermo Garcia-Manero, MD, Hagop Kantarjian, MD, Azra Raza, MD, Ross Levine, MD, Donna Neuberg, ScD, Benjamin L. Ebert, MD, DPhil

Blood (2010) 116 (21): 300.

https://doi.org/10.1182/blood.V116.21.300.300

Published: 2010

Journal Articles

Lenalidomide and Dexamethasone Promote Erythropoiesis in Both Normal and RPS14 and RPS19 shRNA Infected Human CD34+ Cells: Implications for Therapy of Myelodysplastic Syndrome and Diamond-Blackfan Anemia.

Anupama Narla, MD, Shilpee Dutt, Ph.D., J. Randall McAuley, Benjamin L. Ebert, MD, DPhil

Blood (2009) 114 (22): 1092.

https://doi.org/10.1182/blood.V114.22.1092.1092

Published: 2009

NARROW

Inhibition of the CRBN-DDB1-CUL4-ROC1 E3 Ubiquitin Ligase Mediates the Anti-Proliferative and Immunomodulatory Properties of Lenalidomide

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome

Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Lenalidomide and Dexamethasone Promote Erythropoiesis in Both Normal and RPS14 and RPS19 shRNA Infected Human CD34+ Cells: Implications for Therapy of Myelodysplastic Syndrome and Diamond-Blackfan Anemia.

Email alerts

ASH Publications

American Society of Hematology

Inhibition of the CRBN-DDB1-CUL4-ROC1 E3 Ubiquitin Ligase Mediates the Anti-Proliferative and Immunomodulatory Properties of Lenalidomide

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome

Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Lenalidomide and Dexamethasone Promote Erythropoiesis in Both Normal and RPS14 and RPS19 shRNA Infected Human CD34+ Cells: Implications for Therapy of Myelodysplastic Syndrome and Diamond-Blackfan Anemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only